Practice Information:
KSB Foot and Ankle Center/ Wound Care Center
Dixon, IL 61021 Residency Director of KSB Hospital; Podiatric Medicine and Surgery Residency with Reconstructive Rearfoot/Ankle Surgery
Clinical Assistant Professor in the Department of Family and Community Medicine at the University of Illinois College of Medicine at Rockford
Certification:
Board Certified in Foot Surgery/ Reconstructive Rearfoot/Ankle
Fellow, American Society of Podiatric Surgeons, July 2009-Present Fellow, American College of Foot and Ankle Surgeons,
Residency Training:
Podiatric Surgical Residency Cambridge Health Alliance affiliated with the Harvard Medical School
Chicago Healthcare System-Westside Division
Education:
Rosalind Franklin Chicago Medical School at Finch University; Dr. William M. Scholl College of Podiatric Medicine
Doctorate in Podiatric Medicine, May 2000 Bachelor of Science in Basic Science, May 1998
Honors Program, 1989-1992 Bachelor of Science, General Science, May 1994 Bachelor of Arts, English, May 1994
Honors/Awards:
President, Illinois Podiatric Medical Association, 2012-Present
Chair, American Society of Podiatric Surgeons, 2012-Present Lecturer, William Goldfarb Podiatric Review, November 2011 President Elect, IPMA September 2011 Inventor, Ex-Fix Ambulator, Patent Number 7,955,333 Novel Hydrophilic Gel Enhances Healing Poster Winner, 2009 Enhanced Wound Healing by Binding Reactive Oxygen Species, 2009 Vice President, Illinois Podiatric Medical Association, 2010 Treasurer, American Society of Podiatric Surgeons July 2011 Secretary, American Society of Podiatric Surgeons July 2009-Present Board of Directors, American Society of Podiatric Surgeons, July 2009-
APMA Marketing Committee, 2008-Present APMA Membership Committee, 2007-2008 Mentor of the Year, Rosalind Franklin University, 2007 Podiatry Political Action Committee Co-Chairman, IL 2006-Present Elected Director at Large, Illinois Board, 2006-Present Elected Secretary of Illinois, 2008-2009 Elected Treasurer of Illinois, 2009-Present Scholl College Mentor of the Year, 2007 Poster Presenter, ACFAS Meeting, Las Vegas, 2006 Elected APMA Young Members Chair, APMA 2005-2007 Poster Presenter, SAWC, San Diego, 2005
Presenter, Graftjacket, Midwest Podiatry Conference, 2005 Elected to the Young Members Committee for the American
Wound Care Task Committee Co-Chairman, KSB Hospital, 2004 Elected to the state Podiatric Legislative Board for Illinois, 2003 Synthes Educational Grant-Advanced Podiatric Symposium, 2002 Poster Presenter 2002 Annual Scientific Meeting of
The American Podiatric Medical Association, Apligraf Research, Seattle, WA, 2002
Poster Presenter 2002 Annual Scientific Meeting of
The American Podiatric Medical Association, Doxepin 5% Cream Research, Seattle, WA, 2002
Poster Presenter at the 17th Annual Clinical Wound Symposium,
Doxepin 5% Cream Research, Baltimore, Maryland, 2002
Poster Presenter at the International Wound Healing Society,
Doxepin 5% Cream Research, Baltimore, Maryland, 2002
National Podiatric Residents Conference Silver Award Winner
Poster Presenter at the 16th Annual Clinical Wound Symposium,
Apligraf Research, Orlando, Florida, 2001
Ortho-McNeil Dermatological Scholarship, 2000
Publications:
Investigation of GraftJacket Regenerative Tissue Matrix For Ulcer Repair on Full-Thickness Lower Extremity Ulcers, White Paper, December 2005
The Evaluation and Comparison Between Two Methods of Bacterial Load Control in Grafskin (Apligraf) Healing Efficacy in Diabetic Foot Ulcers, Podiatry Management, June 2003
The Use of Topical 5% Doxepin Cream to Decrease the Symptoms of Painful Diabetic Neuropathy, Podiatry Today, pages 55-59, October 2002; Biomechanics, pages 71-77, June 2003 Charcot Neuropathic Foot, The First Ray, pages 23-27, Vol. 18, Number 1, 1998
Research:
Pegasus Wound Matrix, 2007-2009; Published in Journal of Podiatric Medical Association, November 2012
Wright Medical: A Randomized, Single-blinded, Multicenter Clinical Study Comparing Graftjacket Regenerative Tissue Matrix for Ulcer Repair with Apligraf on Full-thickness Lower Extremity Ulcers, 2004-2005, Site Head Investigator Wolf Piezon Shockwave Therapy Research for Recalcitrant Plantar
The Use of Topical 5% Doxepin Cream to Decrease the Symptoms
of Painful Diabetic Neuropathy, 2001-2003; Head Investigator
Evaluation and Comparison Between Two Methods of Bacterial
Load Control in Apligraf Healing Efficacy in Diabetic
Foot/Leg Ulcerations, 2000-2003; Head Investigator
Extracurricular Activities:
Speakers Bureau, Shire Regenerative Medicine, 2013-Present President, Illinois Podiatric Medical Association, 2012-Present Chair, American Society of Podiatric Surgeons, 2012-Present Illinois Delegate to the APMA House of Delegate, 2010-Present President Elect, 2011-2012 Lecturer, Quebec Conference, November 2012 Lecturer, Bacterin December 2011 Excellegen Medical Advisory Board, 2012-Present Goldfarb Institute Lecturer, November 2011 Lecturer, IPMA Sept. 2011
Lecturer, Indiana, Sept. 2011 Lecturer, Wild on Wounds, Las Vegas, Sept. 2011
Lecturer New York Clinical Conference, September 2011
American Society of Podiatric Surgeons, Secretary 2009
American Society of Podiatric Surgeons Member 2009-Present
IPMA Secretary, 2009-2010 IPMA State Meeting Lecturer, Pediatrics, 2006 IPMA Medicaid Committee Chairperson, 2007-Present IPMA Continuing Education Committee, 2009 IPMA Development Committee Chairperson, 2009 IPMA Finance Committee, 2009-Present IPMA Bylaws Committee, 2009-Present APMAPAC Co-Coordinator 2005-Present United Way Chairperson, Lee County, 2006-2008 Consultant, Tornier Orthopedics, 2006-Present Board Member, Sauk Valley Bank 2009-Present Consultant, Bacterin Bone Graft 2010-Present Council of Teaching Hospital Liaison for Young Members,
APMA Education Committee, 2005-2007 APMA Membership Committee, 2005-2007 APMA Annual Meeting Committee, 2005-2007 APMA Young Members Committee Chairperson, 2005-2007 APMA MSLC Physicians Recovery Network Subcommittee,
APMA Membership and Student Liaison Committee, 2005-2007 American Heart Association Heartwalk, Chairman, 2005-2007 Consultant, Healthpoint Company, 2005-2009 Consultant, Tornier Orthopedics 2007-Present Consultant, Wright Medical, 2005-Present Lecturer, Illinois Coding Committee, 2004 Lecturer, Healthpoint Company at the APMA meeting, 2004 Lecturer, Illinois Podiatric State Society Meeting, 2003 Guest Lecturer for the Pfizer Corporation, 2003-Present
Member of the APMA and IPMA Diabetes Council, 2000-Present
Member of the APMA and IPMA, July 2003-Present Member, American College of Foot and Ankle Surgeons, July 2003-
Guest Lecturer for IPMA State Society Meeting, 2003, 2006 Guest Lecturer, Diabetic Footcare, KSB Hospital 2003 Educator, Massachusetts Podiatric Society External Fixator
OrthoFix External Fixation Course, 2003 Guest Lecturer of Wound Care for Smith and Nephew
Guest Lecturer on Diabetic Neuropathy for the Healthpoint
Guest Lecturer on Malignant Melanoma Zone 2 Illinois
Faculty member of Midwest Podiatry Conference, 2001-Present
Interviewed on cable Channel 56 Health Segment, “Here’s to Your Health,” August, 2001
Distinguished Lecturer, Dr. William M. Scholl College of
Podiatric Medicine at Finch University, 2001
Licenses:
Licensed Illinois Podiatric Physician 2001-Present
Licensed Massachusetts Podiatric Physician 2002-2003
Advanced Cardiac Life Support License, 2000-Present Cardiopulmonary Resuscitation 1998-Present Member, Association for the Advancement of Wound Care
Janusz Korczak International Newsletter no 16 (16 pages) Amsterdam December 2005. Dear friends and colleagues. The last Korczak Newsletter of 2005. Overlooking all the information in the preceding LETTERS the conclusion must be: a fruitful year. Many activities in the Korczak Associations, conferences, publications, seminars etc. We also noticed that the Korczak Newsletter brought people
DPLA MANUFACTURING PROCESS FOR TADALAFIL FROM RACEMIC OR L-TRYPTOPHAN Introduction Tadalafil 1 is a selective inhibitor of cGMP specific Type V phosphodiesterase (PDE5) and it is used for treatment of erectile dysfunction (Cialis®). The pharmacological activity of Tadalafil is assigned specifically to (6R,12aR)-enantiomer. Since Tadalafil 1 possesses at C(12a)-atom R-configura